Home The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease
Article
Licensed
Unlicensed Requires Authentication

The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease

  • Chiung-Yu Chen , Wei-Lun Tsai , Po-Ju Lin and Shu-Chu Shiesh
Published/Copyright: August 19, 2011

Abstract

Background: Ischemia-modified albumin (IMA), measured by the cobalt-binding capacity of albumin, is a promising biomarker for cardiac ischemia. The IMA-to-serum albumin ratio (IMAR) has been reported to relate to the severity of decompensated liver cirrhosis. This study aimed to assess IMA and IMAR as a liver function test and to investigate whether albumin infusion changes IMAR in patients with liver cirrhosis.

Methods: Blood samples were collected from healthy volunteers (n=51) and patients with chronic hepatitis (n=25), liver cirrhosis (n=24) and uremia (n=13). Parameters examined included serum levels of IMA, albumin, total bilirubin, creatinine, international normalized ratio (INR), model for end-stage liver disease (MELD) score, childturcotte-pugh (CTP) score, indocyanine green (ICG) retention rate and total antioxidant capacity (TAC). Paired serum samples from patients pre- and post-albumin infusion (n=9) were collected and the changes were compared.

Results: IMA and IMAR increased in patients with chronic hepatitis or cirrhosis, as compared to healthy volunteers. In patients with liver disease, IMA and IMAR were significantly associated with ICG retention, bilirubin, TAC and INR. In addition, IMAR was associated with CTP and MELD score in patients with cirrhosis. Albumin therapy improved patients’ serum levels of creatinine and bilirubin and MELD score, but not IMA and IMAR.

Conclusions: IMAR, reflecting liver function and oxidative stress, is a more objective liver function test as it was not affected after a 3-day albumin infusion. More investigations, however, are needed to validate the use of IMAR in cases of chronic liver disease.


Corresponding author: Shu-Chu Shiesh, Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, 1 University Road, Tainan, 70101, Taiwan Phone: +886-6-235-3535 ext. 5764, Fax: +886-6-236-3956,

Received: 2011-6-4
Accepted: 2011-7-24
Published Online: 2011-08-19
Published in Print: 2011-11-01

©2011 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editorial
  2. Thank you, indeed!
  3. Reviews
  4. Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equations
  5. Oxidative stress and diabetes mellitus
  6. Human papilloma virus (HPV) molecular diagnostics
  7. Opinion Papers
  8. Urine immunofixation electrophoresis remains important and is complementary to serum free light chain
  9. Permissible performance limits of regression analyses in method comparisons
  10. General Clinical Chemistry and Laboratory Medicine
  11. The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease
  12. Relationship between bilirubin and C-reactive protein
  13. Status of serum-calcium and -albumin measurement in Argentina assessed in 300 representative laboratories with 20 fresh frozen single donation sera
  14. Practical application of Sigma Metrics QC procedures in clinical chemistry
  15. High-throughput analysis of testosterone in serum samples by on-line solid phase extraction liquid chromatography-tandem mass spectrometry
  16. Monitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy
  17. Phenotype of Gc-globulin influences the macrophage activating factor (MAF) levels in serum
  18. Combination of cellular population data and CytoDiff™ analyses for the diagnosis of lymphocytosis
  19. Eosinophiluria is common among patients after ileal conduit surgery
  20. Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia
  21. Uptake of cobalamin and markers of cobalamin status: a longitudinal study of healthy pregnant women
  22. Vitamin B12 absorption judged by measurement of holotranscobalamin, active vitamin B12: evaluation of a commercially available EIA kit
  23. Salivary markers of oxidative stress and Salivette collection systems
  24. Infectious Diseases
  25. Development of a microwell adapted immunoblot system with recombinant antigens for distinguishing human herpesvirus (HHV)6A and HHV6B and detection of human cytomegalovirus
  26. Cardiovascular Disease
  27. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide
  28. Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort
  29. Letters to the Editor
  30. Iron deficiency prevalence is increased among Helicobacter pylori infected Brazilian patients
  31. Helicobacter pylori infection and iron deficiency in a group of Brazilian patients
  32. Multiplex protein assay performance/evaluation and the requirement for precision and correlation to clinical assays
  33. Functional assay or antigen test for protein C and protein S in ischemic stroke: which shows the greatest change?
Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm.2011.675/html
Scroll to top button